May C. Ong

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Long-term relief of CRPS-associated limb dystonia with ketamine infusion.

Long-term relief of CRPS-associated limb dystonia with ketamine infusion.

Journal: BMJ case reports

Published: March 19, 2026

Multiday intravenous ketamine infusion therapy for the management of central sensitisation syndrome secondary to chronic chemotherapy-induced peripheral neuropathic pain.

Multiday intravenous ketamine infusion therapy for the management of central sensitisation syndrome secondary to chronic chemotherapy-induced peripheral neuropathic pain.

Journal: BMJ case reports

Published: July 04, 2025

Continuous ketamine infusion for the management of opioid-induced hyperalgesia following amputation.

Continuous ketamine infusion for the management of opioid-induced hyperalgesia following amputation.

Journal: BMJ case reports

Published: January 04, 2024

OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study - CORRIGENDUM.

OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study - CORRIGENDUM.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: December 17, 2023

Therapeutic effects of 7- to 14-day subanesthetic ketamine infusions for chronic pain on standardized psychiatric measures.

Therapeutic effects of 7- to 14-day subanesthetic ketamine infusions for chronic pain on standardized psychiatric measures.

Journal: Pain management

Published: September 01, 2023

OnabotulinumtoxinA Reduces Health Resource Utilization in Chronic Migraine: PREDICT Study.

OnabotulinumtoxinA Reduces Health Resource Utilization in Chronic Migraine: PREDICT Study.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: April 25, 2022

The effects of a multiday (10-14 days) subanesthetic dose IV ketamine infusion in the treatment of refractory chronic pain.

The effects of a multiday (10-14 days) subanesthetic dose IV ketamine infusion in the treatment of refractory chronic pain.

Journal: Pain management

Published: September 16, 2021

OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study.

OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: July 05, 2021

Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control.

Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control.

Journal: International journal of clinical practice

Published: May 18, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026